ARTICLE | Company News
Applied Microbiology deal
July 6, 1993 7:00 AM UTC
Separately AMBI was granted U.S. Patent No. 5,217,950 covering the use of lanthionine-containing bacteriocins, a class of antimicrobial proteins, for control of bacterial contamination and infection. ...